Detalhe da pesquisa
1.
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial.
Lancet
; 390(10101): 1499-1510, 2017 Sep 23.
Artigo
Inglês
| MEDLINE | ID: mdl-28750935
2.
Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis.
AIDS
; 35(9): 1333-1342, 2021 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33730748
3.
Pilot study of once-daily simplification therapy with abacavir/lamivudine/zidovudine and efavirenz for treatment of HIV-1 infection.
HIV Clin Trials
; 7(5): 229-36, 2006.
Artigo
Inglês
| MEDLINE | ID: mdl-17162316
4.
Phenotypic impact of HIV reverse transcriptase M184I/V mutations in combination with single thymidine analog mutations on nucleoside reverse transcriptase inhibitor resistance.
AIDS
; 18(12): 1691-6, 2004 Aug 20.
Artigo
Inglês
| MEDLINE | ID: mdl-15280780